Yingwei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yingwei Zhang has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Hong Wang
State Key Laboratory of Chemical Resource Engineering, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China
8 shared publications - Yonggang Ke
Georgia Institute of Technology and Emory University
7 shared publications - Jingqi Tian
School of Chemistry and Chemical Engineering, Yangzhou University, 180 Siwangting Road, Yangzhou 225002, People's Republic of China
5 shared publications - Pengfei Wang
Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, School of Medicine, Renji Hospital, Institute of Molecular Medicine, Shanghai Jiao Tong University, China
5 shared publications Xinhao Li
5 shared publications- Xuping Sun
Sichuan University
5 shared publications
Latest Publications
- 28 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (35) , 47372-47386
A Dual-Mode Fluorescent and Colorimetric Biosensor Based on AuNPs@RCA Nanogel-Integrated Multipedal DNA Walker for Ultrasensitive miRNA Detection
The development of highly sensitive and reliable biosensors is essential for the early diagnosis and therapeutic monitoring of cancer. Herein, we report a dual-mode fluorescence–colorimetric biosensing platform for the ultrasensitive detection of miRNA-21, integrating AuNP-supported dual-stage rolling circle amplification (RCA) with an RCA-generated multipedal binding-and-cleavage mechanism. The sensing hierarchy is initiated by target-dependent activation of the primary RCA on the gold nanoparticle (AuNP) surface, producing long DNA strands with multiple repeated recognition domains that function as numerous walker “legs” and form a DNA-rich nanogel matrix. Through these repeated domains, the RCA-generated multipedal walker repeatedly and multivalently binds fluorophore-labeled hairpin substrates on the AuNP surface, thereby facilitating APE1-mediated substrate cleavage and fluorescence recovery. The APE1-generated cleavage fragments subsequently initiate the secondary RCA following the addition of the T2 template. The two successive RCA reactions ultimately produce an Au@RCA DNA nanogel containing abundant G-quadruplex/hemin DNAzymes that catalyze a visually detectable color change. By integrating the multipedal walker-mediated multivalent binding-and-cleavage process with dual-stage RCA, the platform enables dual-mode fluorescence–colorimetric detection with efficient signal amplification and low background, achieving limits of detection of 9.854 and 790 fM for the fluorescence and colorimetric modes, respectively. Furthermore, the two complementary outputs provide independent signal readouts for cross-validation. The biosensor demonstrated excellent specificity and distinguished the endogenous responses of MCF-7, HeLa, and HEK293T cell lysates. These results support the potential of the platform for ultrasensitive tumor-associated biomarker detection, while the cell-lysate experiments represent a preliminary proof-of-concept evaluation in complex biological matrices.
- 28 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (35) , 47372-47386
A Dual-Mode Fluorescent and Colorimetric Biosensor Based on AuNPs@RCA Nanogel-Integrated Multipedal DNA Walker for Ultrasensitive miRNA Detection
The development of highly sensitive and reliable biosensors is essential for the early diagnosis and therapeutic monitoring of cancer. Herein, we report a dual-mode fluorescence–colorimetric biosensing platform for the ultrasensitive detection of miRNA-21, integrating AuNP-supported dual-stage rolling circle amplification (RCA) with an RCA-generated multipedal binding-and-cleavage mechanism. The sensing hierarchy is initiated by target-dependent activation of the primary RCA on the gold nanoparticle (AuNP) surface, producing long DNA strands with multiple repeated recognition domains that function as numerous walker “legs” and form a DNA-rich nanogel matrix. Through these repeated domains, the RCA-generated multipedal walker repeatedly and multivalently binds fluorophore-labeled hairpin substrates on the AuNP surface, thereby facilitating APE1-mediated substrate cleavage and fluorescence recovery. The APE1-generated cleavage fragments subsequently initiate the secondary RCA following the addition of the T2 template. The two successive RCA reactions ultimately produce an Au@RCA DNA nanogel containing abundant G-quadruplex/hemin DNAzymes that catalyze a visually detectable color change. By integrating the multipedal walker-mediated multivalent binding-and-cleavage process with dual-stage RCA, the platform enables dual-mode fluorescence–colorimetric detection with efficient signal amplification and low background, achieving limits of detection of 9.854 and 790 fM for the fluorescence and colorimetric modes, respectively. Furthermore, the two complementary outputs provide independent signal readouts for cross-validation. The biosensor demonstrated excellent specificity and distinguished the endogenous responses of MCF-7, HeLa, and HEK293T cell lysates. These results support the potential of the platform for ultrasensitive tumor-associated biomarker detection, while the cell-lysate experiments represent a preliminary proof-of-concept evaluation in complex biological matrices.
- 27 October 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (11) , 8801-8808
A Triple-Input AND-Logic System Employing an APE1-Propelled Bipedal DNA Walker for Highly Sensitive Detection of Dual miRNAs
The escalating global cancer burden necessitates the development of precise tumor-specific microRNA (miRNA) detection strategies. However, the low-abundance, short-length, and high-sequence homology of miRNAs significantly hinder their accurate detection. Moreover, growing evidence of miRNA codysregulation in tumorigenesis underscores the diagnostic advantage of multiplexed analysis over single-marker approaches. Here, we present a novel bipedal DNA walker-based biosensor (BDWA) assembled on gold nanoparticles for the simultaneous detection of dual-miRNA targets. This system uniquely integrates dual-miRNA responsiveness with tumor-endogenous enzyme-driven signal amplification operating within a triple-input orthogonal AND-logic gate framework to enhance diagnostic specificity. Specifically, the concurrent presence of miR-21 and miR-155 displaces blocking strands to activate the walker, while the tumor-associated endonuclease APE1 serves as an intracellular trigger that propels the walker along engineered hairpin tracks (H1) on AuNPs. APE1-mediated cleavage of abasic (AP) sites results in the release and amplification of fluorescence signals initiated by the dual-targets. The bipedal architecture of the walker ensures a high processivity and efficient signal amplification. Critically, this design produces output signals only when all three inputs─miR-21, miR-155, and APE1─are present, thereby minimizing background interference and false positives. The BDWA system demonstrates high sensitivity and specificity for dual-miRNA detection in tumor cell lysates and intracellular imaging, offering a robust, tumor-activated, and programmable molecular platform for next-generation cancer diagnostics.
- 27 October 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (11) , 8801-8808
A Triple-Input AND-Logic System Employing an APE1-Propelled Bipedal DNA Walker for Highly Sensitive Detection of Dual miRNAs
The escalating global cancer burden necessitates the development of precise tumor-specific microRNA (miRNA) detection strategies. However, the low-abundance, short-length, and high-sequence homology of miRNAs significantly hinder their accurate detection. Moreover, growing evidence of miRNA codysregulation in tumorigenesis underscores the diagnostic advantage of multiplexed analysis over single-marker approaches. Here, we present a novel bipedal DNA walker-based biosensor (BDWA) assembled on gold nanoparticles for the simultaneous detection of dual-miRNA targets. This system uniquely integrates dual-miRNA responsiveness with tumor-endogenous enzyme-driven signal amplification operating within a triple-input orthogonal AND-logic gate framework to enhance diagnostic specificity. Specifically, the concurrent presence of miR-21 and miR-155 displaces blocking strands to activate the walker, while the tumor-associated endonuclease APE1 serves as an intracellular trigger that propels the walker along engineered hairpin tracks (H1) on AuNPs. APE1-mediated cleavage of abasic (AP) sites results in the release and amplification of fluorescence signals initiated by the dual-targets. The bipedal architecture of the walker ensures a high processivity and efficient signal amplification. Critically, this design produces output signals only when all three inputs─miR-21, miR-155, and APE1─are present, thereby minimizing background interference and false positives. The BDWA system demonstrates high sensitivity and specificity for dual-miRNA detection in tumor cell lysates and intracellular imaging, offering a robust, tumor-activated, and programmable molecular platform for next-generation cancer diagnostics.
- 5 August 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (35) , 20199-20206
Sensitive detection of miRNA-141 using an endogenous dual-switch activated bipedal DNAzyme walker biosensor
We developed an endogenous dual-gated fluorescence biosensor by leveraging miRNA-141 and APE1 overexpression in tumors, employing a cascade dual-amplification strategy via strand displacement and bipedal DNAzyme walking.
- 5 August 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (35) , 20199-20206
Sensitive detection of miRNA-141 using an endogenous dual-switch activated bipedal DNAzyme walker biosensor
We developed an endogenous dual-gated fluorescence biosensor by leveraging miRNA-141 and APE1 overexpression in tumors, employing a cascade dual-amplification strategy via strand displacement and bipedal DNAzyme walking.
- 2 July 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 166, 109037
Platinum–zinc oxide as a super signal amplifier for ultrasensitive electrochemical immunodetection of CEA
- 2 July 2025
- Published by Elsevier in Bioelectrochemistry
- Vol. 166, 109037
Platinum–zinc oxide as a super signal amplifier for ultrasensitive electrochemical immunodetection of CEA
- 26 February 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (13) , 8153-8160
A dual-switch fluorescence biosensor with an entropy-driven and DNA walker cascade amplification circuit for sensitive microRNA detection
We developed a dual-switch fluorescence biosensor that integrates a two-step cascade signal amplification circuit of EDC and DNA walker on AuNP for sensitive miRNA detection, enabling the effective differentiation of cancer cells from normal cells.
- 26 February 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (13) , 8153-8160
A dual-switch fluorescence biosensor with an entropy-driven and DNA walker cascade amplification circuit for sensitive microRNA detection
We developed a dual-switch fluorescence biosensor that integrates a two-step cascade signal amplification circuit of EDC and DNA walker on AuNP for sensitive miRNA detection, enabling the effective differentiation of cancer cells from normal cells.
- 14 July 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 262, 116566
Synergistic powering of DNA walker movement by endogenous dual enzymes for constructing dual-mode biosensors
- 14 July 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 262, 116566
Synergistic powering of DNA walker movement by endogenous dual enzymes for constructing dual-mode biosensors
Simulation‐Guided Rational Design of DNA Walker‐Based Theranostic Platform
Biomolecule‐functionalized nanoparticles represent a type of promising biomaterials in biomedical applications owing to their excellent biocompatibility and versatility. DNA‐based reactions on nanoparticles have enabled emerging applications including intelligent biosensors, drug delivery, and biomimetic devices. Among the reactions, strand hybridization is the critical step to control the sensitivity and specificity of biosensing, and the efficiency of drug delivery. However, a comprehensive understanding of DNA hybridization on nanoparticles is still lacking, which may differ from the process in homogeneous solutions. To address this limitation, coarse‐grained model‐based molecular dynamic simulation is harnessed to disclose the critical factors involved in intermolecular hybridization. Based on simulation guidance, DNA walker‐based smart theranostic platform (DWTP) based on “on‐particle” hybridization is developed, showing excellent consistency with simulation. DWTP is successfully applied for highly sensitive miRNA 21 detection and tumor‐specific miRNA 21 imaging, driven by tumor‐endogenous APE 1 enzyme. It enables the precise release of antisense oligonucleotide triggered by tumor‐endogenous dual‐switch miRNA 21 and APE 1, facilitating effective gene silencing therapy with high biosafety. The simulation of “on‐particle” DNA hybridization has improved the corresponding biosensing performance and the release efficiency of therapeutic agents, representing a conceptually new approach for DNA‐based device design.
Simulation‐Guided Rational Design of DNA Walker‐Based Theranostic Platform
Biomolecule‐functionalized nanoparticles represent a type of promising biomaterials in biomedical applications owing to their excellent biocompatibility and versatility. DNA‐based reactions on nanoparticles have enabled emerging applications including intelligent biosensors, drug delivery, and biomimetic devices. Among the reactions, strand hybridization is the critical step to control the sensitivity and specificity of biosensing, and the efficiency of drug delivery. However, a comprehensive understanding of DNA hybridization on nanoparticles is still lacking, which may differ from the process in homogeneous solutions. To address this limitation, coarse‐grained model‐based molecular dynamic simulation is harnessed to disclose the critical factors involved in intermolecular hybridization. Based on simulation guidance, DNA walker‐based smart theranostic platform (DWTP) based on “on‐particle” hybridization is developed, showing excellent consistency with simulation. DWTP is successfully applied for highly sensitive miRNA 21 detection and tumor‐specific miRNA 21 imaging, driven by tumor‐endogenous APE 1 enzyme. It enables the precise release of antisense oligonucleotide triggered by tumor‐endogenous dual‐switch miRNA 21 and APE 1, facilitating effective gene silencing therapy with high biosafety. The simulation of “on‐particle” DNA hybridization has improved the corresponding biosensing performance and the release efficiency of therapeutic agents, representing a conceptually new approach for DNA‐based device design.